Blog

Location: Cambridge

Allison MacLeod

As CMO of Flywire (Nasdaq: FLYW), Allison sets the company’s marketing and revenue operations strategy worldwide. Since joining Flywire in 2019, Allison has led the growth of its marketing function, building out new teams in APAC and EMEA, and scaling up a new revenue operations function. Allison was also instrumental in leading Flywire to its successful IPO in May, 2021.

She has more than 15 years of marketing experience, including seven years at Rapid7 (Nasdaq: RPD). There, she focused on building and optimizing the company’s growth by building and scaling demand generation, business development, and operations. Previously, she worked at Forrester in several digital and field-based roles.

Allison is on the Board of Trustees of the Massachusetts Technology Leadership Council, and serves as strategic advisor to early-stage companies. Allison holds a Master of Arts in Integrated Marketing from Emerson College, and a Bachelor of Arts in Communications from the University of Massachusetts, Amherst.

Cameron Raglin

Cameron Raglin is an Associate at F-Prime, focusing on early-stage investments in healthcare technology and services companies. Prior to joining F-Prime, Cameron was a Consultant at Bain & Company, where he advised healthcare Private Equity transactions and business strategy for Fortune 100 healthcare and technology companies. He also served as a Senior Analyst at Twist Bioscience, focusing on corporate strategy, business development, and company operations.

Cameron holds a B.A. in History from Amherst College, with a minor focus in Physics and Pre-Medicine.

Michelle Goodrich

Michelle Goodrich joined F-Prime as a Manager of Human Resources to support the development and execution of human resource strategies for the firm. Michelle has over 10 years of experience as an HR professional and brings an extensive background in training and development, benefits, employee relations and human resources compliance.

Prior to F-Prime, she oversaw the HR department for Beacon Hill Staffing Group, a billion-dollar staffing agency located nationwide. She has also held various HR roles in insurance, technology, and hospitality-based industries.

Michelle holds a B.A. in Psychology and minored in Business Administration from The University of Massachusetts Lowell, a graduate certificate in Human Resources Management from The University of Massachusetts – Boston, and is a Certified Professional with The Society for Human Resources Management (SHRM-CP).

Raj Basak, PhD

Raj Basak is a Senior Associate with F-Prime and works across the healthcare sub-sectors including therapeutics, medical technology, and life-sciences tools. Prior to joining F-Prime, Raj was a member of the Healthcare Investment Banking team at Goldman Sachs in New York where he worked on over $15 billion in announced financing and M&A transactions across biopharma.

Raj received his PhD in Molecular Biophysics & Biochemistry from Yale University and was a part of the Program in Physics, Engineering, and Biology (PEB). Raj’s doctoral research focused on studying the biophysical mechanisms underlying nociception in sensory neurons. While in graduate school, Raj was also a Canaan-Yale fellow with Canaan Partners and an analyst with Certara.

Prior to graduate school, Raj worked in laboratories at Columbia University Medical Center and Brown University. His research has been published in Biophysical Journal, Nature, Science Translational Medicine, among others. Raj also holds a B.S. in Physics with Research Honors from The Macaulay Honors College at The City College of New York, where he was awarded the Ward medal. His undergraduate thesis focused on interrogating field theory approaches to quantum tunneling.

Cathy Wong

Cathy Wong joined F-Prime as Senior Director of Finance in July 2023. Cathy has over 14 years of accounting and finance related experience. Prior to joining F-Prime, Cathy worked as a Controller in the GP Services and management company at THL. Earlier in her career, Cathy held various accounting and tax roles at Blackstone, Bain Capital, Bain & Company, and PricewaterhouseCoopers LLP.

Cathy holds a B.S. in Business Administration with dual concentrations in Accounting and Finance from Boston University. She is a certified public accountant in the state of Massachusetts.

Alexander Munoz, MD

Alexander Munoz is a Senior Associate at F-Prime and works across the life sciences sub-sectors including therapeutics and medical technology. Prior to joining F-Prime, Alexander was a consultant at Boston Consulting Group, where he focused on biopharma diligence and commercial go-to-market strategy.

Alexander holds an MD from the Harvard-MIT Health Sciences & Technology (HST) program and an AB in applied mathematics and computer science from Harvard University.

Henry Trapnell

Henry Trapnell joined F-Prime as a Director of Industry Networks to support the firm’s Tech Fund in the U.S. and Eight Roads Ventures abroad. He is a strong believer in the power of community to fuel business growth, and loves connecting portfolio company founders with corporate leaders to build symbiotic partnerships.

Prior to F-Prime, he helped lead digital go-to-market strategy at Google for the company’s hardware & services. He previously advised corporate executives on behalf of J.P. Morgan, where he developed a nuanced understanding of the intersection between emerging technologies, finance, and personal relationships.

Henry graduated from the Stanford Graduate School of Business and studied Economics and Chinese at Boston University. He also serves on the board of the Chestnut Hill Community Association in Philadelphia.

Carolyn Haley, MS, CPA

Carolyn Haley joined F-Prime in 2023 where she serves as a Partner, Chief Operating Officer, and Chief Financial Officer and manages the administrative functions of the firm.

Prior to joining F-Prime, Carolyn was a partner and Global Head of Operations and Finance at GMO LLC where she was responsible for the firm’s strategic operating model and led various functions including Operations, Finance, Tax, Corporate Accounting, Enterprise Data Management and Investment Analysis. She also served as President and Trustee of the GMO Trust group of mutual funds, was a member of the Board of Directors for all of the firm’s subsidiaries and a served on several of the firm’s key governance committees, including the ESG and the Diversity, Equity and Inclusion Groups. Prior to GMO, Carolyn was Treasurer and Chief Compliance Officer at Tekla Capital Management (formerly Hambrecht & Quist Capital Management LLC). Prior to that, she was a senior manager with PricewaterhouseCoopers LLP where she served a broad range of clients in the asset management industry.

Ms. Haley earned her bachelor’s degree in Economics and History from Boston University, graduating magna cum laude, and her Masters of Science in Accounting from the Isenberg School of Management at the University of Massachusetts, Amherst. She is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants and the Massachusetts Society of Certified Public Accountants.

John Shiver, PhD

Dr. John Shiver is a Special Advisor for F-Prime and is also Chief Strategy Officer at IGM ID a wholly owned subsidiary of IGM Biosciences. Established in 2021, IGM ID utilizes a proprietary IgM platform to treat and prevent infectious diseases. The potential utility of this platform for prevention and treatment of infectious diseases is supported by its recent application towards COVID-19 (Ku et al., Nature, published online 03 June 2021).

Prior to joining IGM ID, John was the SVP and Global Head of Vaccines R&D and a member of the Executive Leadership team for 8 years at Sanofi Pasteur, the largest company in the world devoted entirely to vaccines. He previously spent 22 years at Merck & CO where he held a series of senior leadership positions with his last position being VP and Head of Vaccines and Biologics Research. He was a member of Merck Vaccines Integrated Leadership Team and the Global Research Leadership Committee responsible for vaccine research, vaccine clinical assays and biomarkers, and biologics research, and siRNA technologies. Earlier in his career John spent five years at the National Cancer Institute, National Institutes of Health in Bethesda, MD.

John is a recognized expert and industry leader in vaccine and pharmaceutical research and development. He has guided numerous scientific teams that created novel vaccine and monoclonal antibody candidates to prevent or treat more than 40 infectious and non-infectious diseases, including HIV, influenza, HPV, RSV, CMV, pneumococcus, cancer, and asthma. He has collaborated with other senior leaders to secure the licensure of 14 pharmaceutical products spanning both vaccines and monoclonal antibodies, many of which were first- and/or best-in-class products addressing global infectious diseases. He also championed four acquisitions and three major collaborations to obtain new technologies or clinical candidates/products.

John is a Fellow of the American Academy of Microbiology and the International Society of Vaccines (ISV) and a member of multiple advisory boards, including the Board of Directors for the International AIDS Vaccine Initiative (IAVI), Board of Directors for Icosavax, and previously, the Executive Board of the International Society for Vaccines. He has also served on journal editorial boards, including Nature Partner Journals Vaccines and the Journal of Virology. He is the author of more than 150 articles, including 19 in Science, Nature, Cell, and the Proceedings of the National Academy of Sciences and is a co-author of 68 awarded patents. In addition, he is an Adjunct Professor at the University of Pennsylvania College of Medicine and has been recognized by the Financial Times.

John holds a PhD in Physical Chemistry from the University of Florida in Gainesville, FL and completed a postdoctoral fellowship in Biophysics at Purdue University in West Lafayette, IN. He also holds a Bachelor of Science degree in Chemistry and Mathematics from Wofford College in Spartanburg, SC.

Jillian Enos

Jillian Enos is Senior Director of Finance and joined F-Prime in April 2022. Prior to joining F-Prime, she worked at Charlesbank Capital Partners where she held the position of Valuations and Portfolio Reporting Manager. Jill also worked at PwC for six years, most recently as a Manager in their Assurance practice, where she was primarily focused on private equity and private credit fund clients.

Jill earned her BBA in Accounting from the Isenberg School of Management at University of Massachusetts, Amherst and is a certified public accountant in the state of Massachusetts.